Kirmizi Sonmez, N. I. Et Al. 2023. The impact of chiral switch on drug labeling in Turkey: indication, posology, and adverse effects. Marmara Medical Journal , vol.36, no.3 , 351-360.

Kirmizi Sonmez, N. I., Vizdiklar, C., AYDIN, V., Gultekin, O., Bahar, A., & AKICI, A., (2023). The impact of chiral switch on drug labeling in Turkey: indication, posology, and adverse effects. Marmara Medical Journal , vol.36, no.3, 351-360.

Kirmizi Sonmez, Neriman Et Al. "The impact of chiral switch on drug labeling in Turkey: indication, posology, and adverse effects," Marmara Medical Journal , vol.36, no.3, 351-360, 2023

Kirmizi Sonmez, Neriman I. Et Al. "The impact of chiral switch on drug labeling in Turkey: indication, posology, and adverse effects." Marmara Medical Journal , vol.36, no.3, pp.351-360, 2023

Kirmizi Sonmez, N. I. Et Al. (2023) . "The impact of chiral switch on drug labeling in Turkey: indication, posology, and adverse effects." Marmara Medical Journal , vol.36, no.3, pp.351-360.

@article{article, author={Neriman Ipek Kirmizi Sonmez Et Al. }, title={The impact of chiral switch on drug labeling in Turkey: indication, posology, and adverse effects}, journal={Marmara Medical Journal}, year=2023, pages={351-360} }